Terms: = Leukemia AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3 AND Treatment
6 results:
1. Werner helicase mediates the senescence and cell cycle of leukemia cells by regulating DNA repair pathways.
Cui X; Hou J; Wang S; Yu J; Cheng S; Yu L; Song FJ; Luo H
Int J Biol Macromol; 2024 Jan; 255():128305. PubMed ID: 37992942
[TBL] [Abstract] [Full Text] [Related]
2. wrn-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
Moles R; Bai XT; Chaib-Mezrag H; Nicot C
J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440
[TBL] [Abstract] [Full Text] [Related]
3. Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair.
Castaño J; Herrero AB; Bursen A; González F; Marschalek R; Gutiérrez NC; Menendez P
Oncotarget; 2016 May; 7(21):30440-52. PubMed ID: 27119507
[TBL] [Abstract] [Full Text] [Related]
4. Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome.
Seiter K; Qureshi A; Liu D; Galvin-Parton P; Arshad M; Agoliati G; Ahmed T
Leuk Lymphoma; 2005 Jul; 46(7):1091-5. PubMed ID: 16019564
[TBL] [Abstract] [Full Text] [Related]
5. Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution.
Cheng WH; von Kobbe C; Opresko PL; Fields KM; Ren J; Kufe D; Bohr VA
Mol Cell Biol; 2003 Sep; 23(18):6385-95. PubMed ID: 12944467
[TBL] [Abstract] [Full Text] [Related]
6. Chemotherapy versus transplants for acute myelogenous leukemia in second remission.
Gale RP; Horowitz MM; Rees JK; Gray RG; Oken MM; Estey EH; Kim KM; Zhang MJ; Ash RC; Atkinson K; Champlin RE; Dicke KA; Gajewski JL; Goldman JM; Helbig W; Henslee-Downey PS; Hinterberger W; Jacobsen N; Keating A; Klein JP; Marmont AM; Prentice HG; Reiffers J; Rimm AA; Bortin MM
Leukemia; 1996 Jan; 10(1):13-9. PubMed ID: 8558917
[TBL] [Abstract] [Full Text] [Related]
